APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)

Adherence to Oral Therapies in Advanced Breast and Prostate Cancers

NCT06435546 ·Status: COMPLETED ·Phase: NA

Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer

NCT01298362 ·Status: COMPLETED

Compliance to a Hormone Therapy Regimen in Breast Cancer

NCT00666822 ·Status: COMPLETED

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

NCT01081509 ·Status: COMPLETED

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

NCT00544986 ·Status: COMPLETED ·Phase: PHASE4

Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

NCT00332852 ·Status: COMPLETED ·Phase: PHASE3

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer

NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3

Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women

NCT02914158 ·Status: RECRUITING ·Phase: PHASE3

Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor

NCT01765049 ·Status: ACTIVE_NOT_RECRUITING

Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer

NCT00082277 ·Status: COMPLETED ·Phase: PHASE4

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

NCT00002460 ·Status: UNKNOWN ·Phase: PHASE3

Breast Cancer Tumor Care Observational Programme

NCT00660244 ·Status: COMPLETED

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

NCT00291759 ·Status: COMPLETED ·Phase: PHASE3

Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

NCT00542594 ·Status: TERMINATED

Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors

NCT04651452 ·Status: COMPLETED ·Phase: NA

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

NCT05801705 ·Status: UNKNOWN

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy

NCT02300675 ·Status: COMPLETED ·Phase: NA

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3

Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

NCT04554927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

NCT00078832 ·Status: COMPLETED ·Phase: PHASE3

PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY

NCT03423199 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer

NCT00002529 ·Status: COMPLETED ·Phase: PHASE3

S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer

NCT01515800 ·Status: COMPLETED ·Phase: NA

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

NCT00295646 ·Status: COMPLETED ·Phase: PHASE3